Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Tirofiban for No-Reflow in STEMI
NCT02054000Phase 4Completed
- Sponsor
- Erciyes University
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tirofiban in no-reflow phenomenon, sponsored by Erciyes University. Primary endpoint: In-hospital mortality at 8 days. Started Jan 2011; status: completed.
02
Drugs
tirofiban
03
Conditions
no-reflow phenomenon
Beyond the preview
Go deeper on NCT02054000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054000.